Argentine companies operating in the same pharmaceuticals: major industry
The list below has Argentine companies that operate under the same industry, pharmaceuticals: major. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 or those with the best price dynamics like BIOGEN INC CEDEAR EAC 13 RE 1 COM(USD), thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 957.71 T ARS | 15.95 USD | +4.59% | 212 | 0.92 | 86.62 | 189.84 ARS | +381.39% | 0.32% | Health technology | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 957.71 T ARS | 18,850 ARS | +2.72% | 2.63 K | 0.40 | 99.30 | 189.84 ARS | +513.89% | 0.32% | Health technology | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 438.73 T ARS | 10.35 USD | −1.90% | 180 | 0.20 | 18.59 | 597.27 ARS | +144.56% | 1.69% | Health technology | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 438.73 T ARS | 1,300 ARS | 0.00% | 25 | 4.31 | — | — | — | — | Health technology | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 438.73 T ARS | 12,325 ARS | −0.60% | 2.05 K | 0.06 | 20.64 | 597.27 ARS | +206.49% | 1.69% | Health technology | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 374.94 T ARS | 18.75 USD | +2.46% | 33 | 0.43 | 9.10 | 2,124.76 ARS | +107.54% | 1.81% | Health technology | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 374.94 T ARS | 22,350 ARS | +3.35% | 1.08 K | 1.37 | 10.52 | 2,124.76 ARS | +164.67% | 1.81% | Health technology | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 253.71 T ARS | 34.75 USD | 0.00% | 5 | 0.21 | 43.91 | 815.85 ARS | +207.61% | 1.68% | Health technology | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 253.71 T ARS | 41,675 ARS | +0.18% | 80 | 0.05 | 51.08 | 815.85 ARS | +292.28% | 1.68% | Health technology | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 248.8 T ARS | 33,225 ARS | −0.75% | 17 | 0.20 | 5.66 | 5,874.32 ARS | −4.22% | 3.80% | Health technology | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 236.09 T ARS | 17.00 USD | +1.19% | 166 | 1.16 | — | — | — | 2.11% | Health technology | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 236.09 T ARS | 19,875 ARS | +4.47% | 1.25 K | 0.43 | — | — | — | 2.11% | Health technology | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 151.82 T ARS | 5.85 USD | +1.56% | 956 | 0.60 | 18.99 | 317.52 ARS | — | 3.96% | Health technology | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 151.82 T ARS | 6,930 ARS | +1.61% | 5.22 K | 0.22 | 21.83 | 317.52 ARS | — | 3.96% | Health technology | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 116.42 T ARS | 19,075 ARS | −2.05% | 881 | 2.29 | — | −1,193.64 ARS | −422.98% | 2.94% | Health technology | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 88.44 T ARS | 9.45 USD | +5.70% | 6 | 0.10 | 27.93 | 348.78 ARS | +40.76% | 2.99% | Health technology | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 88.44 T ARS | 11,175 ARS | −0.67% | 75 | 0.35 | 32.04 | 348.78 ARS | +79.50% | 2.99% | Health technology | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 20.56 T ARS | 9.48 USD | +12.86% | 48 | 2.24 | 12.56 | 778.26 ARS | +284.16% | 0.00% | Health technology | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 20.56 T ARS | 10,950 ARS | −1.13% | 421 | 1.13 | 14.07 | 778.26 ARS | +389.90% | 0.00% | Health technology | — |
 RICHLABORATORIOS RICHMOND SACIF | 104.17 B ARS | 1,360 ARS | +5.43% | 15.76 K | 1.69 | 5.18 | 262.78 ARS | — | 0.00% | Health technology | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.83 B ARS | 90.0 ARS | 0.00% | 250 | 0.03 | 21.08 | 4.27 ARS | +64.50% | 0.00% | Health technology | — |